X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-28 | OLMA | Harmon Cyrus | Dir | S - Sale | $10.97 | -20,000 | 948,311 | -2% | -$219,400 | ||||||
2024-02-29 | OLMA | Harmon Cyrus | Dir | S - Sale | $12.41 | -25,000 | 968,311 | -3% | -$310,309 | ||||||
| M | 2024-01-31 | OLMA | Harmon Cyrus | Dir | S - Sale | $12.79 | -30,000 | 993,311 | -3% | -$383,550 | |||||
2023-12-29 | OLMA | Harmon Cyrus | Dir | S - Sale | $13.38 | -25,000 | 1,023,311 | -2% | -$334,500 | ||||||
| M | 2023-09-12 | OLMA | Graham G. Walmsley | Dir | P - Purchase | $10.74 | +640,000 | 4,383,875 | +17% | +$6,871,279 | |||||
2023-12-06 | OLMA | Paradigm Biocapital Advisors LP | 10% | P - Purchase | $11.60 | +100,000 | 7,903,600 | +1% | +$1,160,000 | ||||||
2023-11-30 | OLMA | Harmon Cyrus | Dir | S - Sale | $12.57 | -25,000 | 1,048,311 | -2% | -$314,250 | ||||||
| M | 2023-11-21 | OLMA | Harmon Cyrus | Dir | S - Sale | $14.39 | -8,181 | 1,073,311 | -1% | -$117,740 | |||||
| M | 2023-11-21 | OLMA | Zojwalla Naseem | CHIEF MEDICAL OFFICER | S - Sale | $14.38 | -14,556 | 30,664 | -32% | -$209,296 | |||||
| M | 2023-11-21 | OLMA | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $14.40 | -13,629 | 741,776 | -2% | -$196,233 | |||||
| M | 2023-11-21 | OLMA | Bohen Sean | Pres, CEO | S - Sale | $14.40 | -57,225 | 144,925 | -28% | -$824,134 | |||||
| M | 2023-11-21 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL Offic | S - Sale | $14.39 | -18,742 | 424,987 | -4% | -$269,656 | |||||
2023-11-08 | OLMA | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $17.61 | -200 | 728,947 | 0% | -$3,522 | ||||||
| M | 2023-11-01 | OLMA | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $15.26 | -10,541 | 729,147 | -1% | -$160,806 | |||||
| M | 2023-10-31 | OLMA | Harmon Cyrus | Dir | S - Sale | $12.65 | -30,000 | 1,065,742 | -3% | -$379,450 | |||||
2023-09-29 | OLMA | Harmon Cyrus | Dir | S - Sale | $12.41 | -25,000 | 1,095,742 | -2% | -$310,250 | ||||||
2023-09-19 | OLMA | Myles David C. | CH. DISCOV., NON-CLIN DEV OFF | S - Sale | $12.67 | -20,000 | 739,688 | -3% | -$253,400 | ||||||
| D | 2023-09-12 | OLMA | Bvf Partners L P/il | Dir, 10% | P - Purchase | $9.84 | +1,505,932 | 623,707 | -171% | +$14,818,371 | |||||
| M | 2023-08-31 | OLMA | Harmon Cyrus | Dir | S - Sale | $10.26 | -25,000 | 1,120,742 | -2% | -$256,600 | |||||
| A | 2023-08-16 | OLMA | Harmon Cyrus | Dir | S - Sale | $10.14 | -15,000 | 1,023,714 | -1% | -$152,100 | |||||
2023-08-16 | OLMA | Harmon Cyrus | Dir | S - Sale | $10.14 | -15,000 | 1,145,742 | -1% | -$152,100 | ||||||
2023-06-08 | OLMA | Harmon Cyrus | Dir | S - Sale | $6.30 | -10,000 | 1,160,742 | -1% | -$63,000 | ||||||
| M | 2023-06-05 | OLMA | Harmon Cyrus | Dir | S - Sale | $6.17 | -10,000 | 1,170,742 | -1% | -$61,700 | |||||
2023-04-06 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL Offic | P - Purchase | $0.00 | +10,000 | 396,197 | +3% | +$0 | ||||||
| A | 2022-09-21 | OLMA | Bohen Sean | Pres, CEO | P - Purchase | $0.00 | +20,000 | 74,279 | +37% | +$0 | |||||
2022-09-02 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL Offic | P - Purchase | $0.00 | +20,000 | 381,197 | +6% | +$0 | ||||||
| D | 2022-06-10 | OLMA | Bvf Partners L P/il | Dir, 10% | P - Purchase | $4.03 | +200,000 | 3,378,009 | +6% | +$806,900 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |